1 – 10 of 38
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Using imlifidase to elucidate the characteristics and importance of anti-GBM antibodies produced after start of treatment
2024) In Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 39(1). p.45-54(
- Contribution to journal › Article
- 2023
-
Mark
Regulatory B-cells are reduced in the blood in patients with granulomatosis with polyangiitis, and fail to regulate T-cell IFN-γ production
(
- Contribution to journal › Article
-
Mark
Causes of nephrotic syndrome in Sweden: The relevance of clinical presentation and demographics
(
- Contribution to journal › Article
- 2020
-
Mark
Antiglomerular basement membrane disease
2020) p.4943-4950(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2019
-
Mark
Anti-glomerular basement membrane disease : an update on subgroups, pathogenesis and therapies
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Increased platelet activation occurs in cystic fibrosis patients and correlates to clinical status
(
- Contribution to journal › Article
-
Mark
Routinely used immunoassays do not detect circulating anti-GBM antibodies against native NC1 hexamer and EA epitope of the α3 chain of type IV collagen
(
- Contribution to journal › Article
- 2015
-
Mark
BPI-ANCA Provides Additional Clinical Information to Anti-Pseudomonas Serology: Results from a Cohort of 117 Swedish Cystic Fibrosis Patients.
(
- Contribution to journal › Article
-
Mark
Circulating microRNA expression pattern separates patients with anti-neutrophil cytoplasmic antibody associated vasculitis from healthy controls.
(
- Contribution to journal › Article
-
Mark
Increased levels of neutrophil extracellular trap remnants in the circulation of patients with small vessel vasculitis, but an inverse correlation to anti-neutrophil cytoplasmic antibodies during remission.
(
- Contribution to journal › Article